Using Genome Mapping to Fight Antibiotic Resistance Bacteria

Share this content:
Whole genome sequencing is being used by the US Food and Drug Administration to combat the global spread of antibiotic resistance bacteria.
Whole genome sequencing is being used by the US Food and Drug Administration to combat the global spread of antibiotic resistance bacteria.

According to a US Food and Drug Administration (FDA) consumer report, "The Centers for Disease Control and Prevention (CDC) reports that every year at least 2 million illnesses and 23,000 deaths in the United States are caused by antibiotic-resistant bacteria."1 As a consequence, the FDA is using whole genome sequencing to help identify the presence of antibiotic-resistant bacteria as early as possible.

Watch this short video on FDA's whole genome sequencing technology.

Reference

  1. Cutting-Edge Technology Sheds Light on Antibiotic Resistance. US Food and Drug Administration website. http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm519931.htm. Updated September 15, 2016.  Accessed September 29, 2016.

You must be a registered member of Infectious Disease Advisor to post a comment.

Sign Up for Free e-newsletters